Zyprexa Settlement Back in Court

As I've noted before, over the summer Eli Lilly settled a lawsuit brought in federal court in New York by thousands of patients who'd taken the atypical antipsychotic Zyprexa. Many of these people developed diabetes. The settlement was for $750 million and, for some reason, escaped media notice, despite the fact that it caused a major pharma company to incur a loss for one quarter. Anyhow, now a lawyer has challenged that settlement in court on technical grounds, and once again the media is ignorning the existence of the settlement, excepting the fine folks at the Indianapolis Star, who deserve credit for actually writing about the case.